Baraclude en es it fr

Baraclude Brand names, Baraclude Analogs

Baraclude Brand Names Mixture

  • No information avaliable

Baraclude Chemical_Formula


Baraclude RX_link

Baraclude fda sheet

Baraclude FDA

Baraclude msds (material safety sheet)

Baraclude MSDS

Baraclude Synthesis Reference

No information avaliable

Baraclude Molecular Weight

733.927 g/mol

Baraclude Melting Point

191 oC

Baraclude H2O Solubility

Slightly soluble (1.44 mg/L)

Baraclude State


Baraclude LogP


Baraclude Dosage Forms

Capsule; Capsule (enteric-coated); Liquid; Ointment; Powder; Powder for solution; Solution; Suspension; Tablet; Tablet (enteric-coated)

Baraclude Indication

For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough), as adjunct to antitoxin in infections due to Corynebacterium diphtheriae, in the treatment of infections due to Corynebacterium minutissimum, intestinal amebiasis caused by Entamoeba histolytica, acute pelvic inflammatory disease caused by Neisseria gonorrhoeae, skin and soft tissue infections of mild to moderate severity caused by Streptococcus pyogenes and Staphylococcus aureus, primary syphilis caused by Treponema pallidum, infections caused by Chlamydia trachomatis, nongonococcal urethritis caused by Ureaplasma urealyticum, and Legionnaires' disease caused by Legionella pneumophila.

Baraclude Pharmacology

Erythromycin is produced by a strain of Streptomyces erythraeus and belongs to the macrolide group of antibiotics. After absorption, erythromycin diffuses readily into most body fluids. In the absence of meningeal inflammation, low concentrations are normally achieved in the spinal fluid, but the passage of the drug across the blood-brain barrier increases in meningitis. Erythromycin is excreted in breast milk. The drug crosses the placental barrier, but fetal plasma levels are low. Erythromycin is not removed by peritoneal dialysis or hemodialysis.

Baraclude Absorption

Orally administered erythromycin base and its salts are readily absorbed in the microbiologically active form. Topical application of the ophthalmic ointment to the eye may result in absorption into the cornea and aqueous humor.

Baraclude side effects and Toxicity

Symptoms of overdose include diarrhea, nausea, stomach cramps, and vomiting.

Baraclude Patient Information

Baraclude Organisms Affected

Enteric bacteria and other eubacteria